Int J Mol Sci June 2025 PMID 40650011

Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice.

Gonzalo Olmedo-Saura, Eugenio Bernardi, Lidia Bojtos, Saül Martínez-Horta, Javier Pagonabarraga, Jaime Kulisevsky, Jesús Pérez-Pérez

Mentions

12
Peak: 2 in Jan 2026
across 3 sources since Jul 2025

Extended reach

465
potential audience

Total likes

0

Video views

6

Mentions per month

Jul 2025 – Jan 2026

Where it's discussed

  • Blogs9 articles
  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The analysis reflects a generally positive perception of the article, with discussions pointing out its emphasis on tailored treatments and the need for further research. Phrases like 'important update' and 'crucial insights' demonstrate optimism, while references to 'personalized approaches' and 'multidisciplinary care' highlight the review's practical significance.

AgreementModerate agreement

Most discussions agree that the review provides valuable insights into managing Huntington's Disease symptoms, with comments emphasizing agreement with its emphasis on personalized and multidisciplinary approaches.

InterestHigh interest

The discussions show high interest, as many posts express curiosity about new treatments and implications for patient care, reflected in phrases like 'important update' and 'critical breakthrough'.

EngagementModerate engagement

Posts frequently reference specific aspects of the review, such as the emphasis on understanding mechanisms or new therapies, indicating a moderate level of thoughtful engagement.

ImpactModerate impact

Several users highlight the potential influence of this review on future research and clinical practice, suggesting perceived importance, though some view it as an initial step rather than a definitive solution.

Abstract in brief

  • Huntington's disease (HD) is a common hereditary neurodegenerative disorder that affects movement, cognition, and mental health.
  • Currently, there are no proven disease-modifying treatments, so managing symptoms with medication and therapy is essential, even though high-quality clinical trial evidence is limited.
  • The review emphasizes understanding the disease's underlying mechanisms to guide personalized treatment, highlights new therapies, and stresses the importance of a multidisciplinary approach, including non-drug interventions, to improve patient quality of life.]

Top posts

Most liked on X and Bluesky
Ingentium Huntington's Disease
@ingentium_hd · X

Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice. https://t.co/KKCCbsEhyX https://t.co/CsEDwUE4He

Jul 13, 2025 · 369 followers View post →

All mentions

Ingentium Huntington's Disease
@ingentium_hd · X

Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice. https://t.co/KKCCbsEhyX https://t.co/CsEDwUE4He

Jul 13, 2025 · 369 followers View post →
Unawareness of motor phenoconversion in Huntington disease ...
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Emily S. Fitzgerald,; Jessica E. Manousakis,; Yifat Glikmann-Johnston,; Meg Rankin,; Clare Anderson,; Julie C ...

Jan 1, 2026 View →
Clinical recommendations to guide physical therapy practice for ...
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Changyeon Won,; Woohyuk Jang,; Sunwook Park,. Effectiveness of Lee Silverman Voice Treatment (LSVT)-BIG for ...

Jan 1, 2026 View →
Dosage effects of riluzole in Huntington's disease | Neurology
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Maryam Alsadat Mousavi,; Maliheh Rezaei,; Mahsa Pourhamzeh,; Mehri Salari,; Nikoo Hossein-Khannazer ...

Jan 1, 2026 View →
Long-term effects of tetrabenazine in hyperkinetic movement disorders
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. David M. Taylor,; Thomas R. E. Barnes,; Allan H. Young,. Schizophrenia and Related Psychoses, The Maudsley ...

Jan 1, 2026 View →
Torsion dystonia | Neurology
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Vassilena Iankova,; Susanne A. Schneider,. Secondary Dystonia, International Compendium of Movement Disorders ...

Jan 1, 2026 View →
A Pilot Study to Evaluate the Efficacy of Dextromethorphan ...
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Seema Sharma,; Inderpreet Kaur,; Naina Dubey,; Neelima Goswami,; Sampat Singh Tanwar,. Berberine can be a ...

Jan 1, 2026 View →
Analyses of the Phase 3 Trial of Pridopidine's Outcome on Function ...
Blogs

International Journal of Molecular Sciences, 26, 13, (6220), (2025).https://doi.org/10.3390/ijms26136220 · Crossref. Yigal Paul Goldberg ...

Apr 9, 2024 View →
Mild cognitive impairment in prediagnosed Huntington disease ...
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Luis A. Sierra,; Japleen Kaur,; Samuel A. Frank,; Mark A. Halko,; Rosie E. Curiel Cid,; David A ...

Jul 7, 2010 View →
The gait abnormality of Huntington's disease | Neurology
Blogs

https://doi.org/10.3390/ijms26136220 · Crossref. Sameera Khan,; Nargis Bano,; Shakir Ahamad,; Nawab John Dar,; Aamir Nazir,; Shahnawaz Ali Bhat ...

Oct 1, 1985 View →